The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design
Open accessAbstract
Glycoconjugate vaccines have provided enormous health benefits globally, but they have been less successful in some populations at high risk for developing disease. To identify new approaches to enhancing glycoconjugate effectiveness, we investigated molecular and cellular mechanisms governing the immune response to a prototypical glycoconjugate vaccine. We found that in antigen-presenting cells a carbohydrate epitope is generated upon endolysosomal processing of group B streptococcal type III polysaccharide coupled to a carrier protein. In conjunction with a carrier protein–derived peptide, this carbohydrate epitope binds major histocompatibility class II (MHCII) and stimulates carbohydrate-specific CD4+ T cell clones to produce interleukins 2 and 4—cytokines essential for providing T cell help to antibody-producing B cells. An archetypical glycoconjugate vaccine that we constructed to maximize the presentation of carbohydrate-specific T cell epitopes is 50–100 times more potent and substantially more protective in a neonatal mouse model of group B Streptococcus infection than a vaccine constructed by methods currently used by the vaccine industry. Our discovery of how glycoconjugates are processed resulting in presentation of carbohydrate epitopes that stimulate CD4+ T cells has key implications for glycoconjugate vaccine design that could result in greatly enhanced vaccine efficacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CD1d-Restricted and TCR-Mediated Activation of V α 14 NKT Cells by Glycosylceramides
Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., et al. (1997) · Science · doi:10.1126/science.278.5343.1626 · Cited by 2,400
CD1: Antigen Presentation and T Cell Function
Brigl, M., & Brenner, M. B. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104608 · Cited by 1,035
CD1-Restricted T Cell Recognition of Microbial Lipoglycan Antigens
Sieling, P. A., Chatterjee, D., Porcelli, S. A., Prigozy, T. I., Mazzaccaro, R. J., Soriano, T., Bloom, B. R., Brenner, M. B., Kronenberg, M., Brennan, P. J., et al. (1995) · Science · doi:10.1126/science.7542404 · Cited by 740
Hart, G. W., & Copeland, R. J. (2010) · Cell · doi:10.1016/j.cell.2010.11.008 · Cited by 643
Schneerson, R., Barrera, O., Sutton, A., & Robbins, J. B. (1980) · The Journal of experimental medicine · doi:10.1084/jem.152.2.361 · Cited by 625
Structural Requirements for Glycolipid Antigen Recognition by CD1b-Restricted T Cells
Moody, D. B., Reinhold, B. B., Guy, M. R., Beckman, E. M., Frederique, D. E., Furlong, S. T., Ye, S., Reinhold, V. N., Sieling, P. A., Modlin, R. L., et al. (1997) · Science · doi:10.1126/science.278.5336.283 · Cited by 441
Extensive surface diversity of a commensal microorganism by multiple DNA inversions
Krinos, C. M., Coyne, M. J., Weinacht, K. G., Tzianabos, A. O., Kasper, D. L., & Comstock, L. E. (2001) · Nature · doi:10.1038/35107092 · Cited by 360
Self-citationPolysaccharide processing and presentation by the MHCII pathway
Cobb, B. A., Wang, Q., Tzianabos, A. O., & Kasper, D. L. (2004) · Cell · doi:10.1016/j.cell.2004.05.001 · Cited by 340
Robust immune responses elicited by a fully synthetic three-component vaccine
Ingale, S., Wolfert, M. A., Gaekwad, J., Buskas, T., & Boons, G.-J. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.25 · Cited by 337
Immunology of bacterial polysaccharide antigens
Weintraub, A. (2003) · Carbohydrate Research · doi:10.1016/j.carres.2003.07.008 · Cited by 310
How Bacterial Carbohydrates Influence the Adaptive Immune System
Avci, F. Y., & Kasper, D. L. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101159 · Cited by 238
Self-citationTsuji, M., Mombaerts, P., Lefrancois, L., Nussenzweig, R. S., Zavala, F., & Tonegawa, S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.1.345 · Cited by 211
Self-citationMitchison, N. A. (2004) · Nature Reviews Immunology · doi:10.1038/nri1334 · Cited by 208
Wessels, M. R., Paoletti, L. C., Kasper, D. L., DiFabio, J. L., Michon, F., Holme, K., & Jennings, H. J. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114858 · Cited by 191
Self-citationHigh‐resolution, high‐throughput HLA genotyping by next‐generation sequencing
Bentley, G., Higuchi, R., Hoglund, B., Goodridge, D., Sayer, D., Trachtenberg, E. A., & Erlich, H. A. (2009) · Tissue Antigens · doi:10.1111/j.1399-0039.2009.01345.x · Cited by 185
Haurum, J. S., Arsequell, G., Lellouch, A. C., Wong, S. Y., Dwek, R. A., McMichael, A. J., & Elliott, T. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.2.739 · Cited by 184
Zwitterionic Polysaccharides Stimulate T Cells by MHC Class II-Dependent Interactions
Kalka-Moll, W. M., Tzianabos, A. O., Bryant, P. W., Niemeyer, M., Ploegh, H. L., & Kasper, D. L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.11.6149 · Cited by 156
Self-citationCD4+ cytolytic T cell clone confers protection against murine malaria.
Tsuji, M., Romero, P. J., Nussenzweig, R. S., & Zavala, F. P. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.172.5.1353 · Cited by 146
Self-citationTrotter, C. L., McVernon, J., Ramsay, M. E., Whitney, C. G., Mulholland, K., Goldblatt, D., Hombach, J., & Kiény, M.-P. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.05.073 · Cited by 142
(1997) · PubMed · Cited by 103
Guttormsen, H., Sharpe, A. H., Chandraker, A. K., Brigtsen, A. K., Sayegh, M. H., & Kasper, D. L. (1999) · Infection and Immunity · doi:10.1128/iai.67.12.6375-6384.1999 · Cited by 101
Self-citationPaoletti, L. C., Wessels, M. R., Rodewald, A. K., Shroff, A. A., Jennings, H. J., & Kasper, D. L. (1994) · Infection and Immunity · doi:10.1128/iai.62.8.3236-3243.1994 · Cited by 98
Self-citationWessels, M. R., Paoletti, L. C., Rodewald, A. K., Michon, F., DiFabio, J., Jennings, H. J., & Kasper, D. L. (1993) · Infection and Immunity · doi:10.1128/iai.61.11.4760-4766.1993 · Cited by 98
Self-citationAbdel‐Motal, U. M., Berg, L., Rosén, A., Bengtsson, M., Thorpe, C. J., Kihlberg, J., Dahmén, J., Magnusson, G., Karlsson, K., & Jondal, M. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260307 · Cited by 85
Duan, J., Avci, F. Y., & Kasper, D. L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800974105 · Cited by 84
Self-citationDzhambazov, B. M., Holmdahl, M., Yamada, H., Lu, S., Vestberg, M., Holm, B., Johnell, O., Kihlberg, J. O., & Holmdahl, R. (2005) · European Journal of Immunology · doi:10.1002/eji.200425637 · Cited by 80
Haurum, J. S., Tan, L., Arsequell, G., Frodsham, P., Lellouch, A. C., Moss, P. A. H., Dwek, R. A., McMichael, A. J., & Elliott, T. J. (1995) · European Journal of Immunology · doi:10.1002/eji.1830251211 · Cited by 76
McFarland, B. J., Sant, A. J., Lybrand, T. P., & Beeson, C. (1999) · Biochemistry · doi:10.1021/bi991393l · Cited by 73
Kamboj, K. K., Kirchner, H. L., Kimmel, R., Greenspan, N. S., & Schreiber, J. R. (2003) · The Journal of Infectious Diseases · doi:10.1086/374785 · Cited by 71
Barrett, D. J. (1985) · Advances in Pediatrics · doi:10.1016/s0065-3101(24)00217-2 · Cited by 63
Specificity of glycopeptide-specific T cells
Deck, B., Elofsson, M., Kihlberg, J. O., & Unanue, E. R. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1074 · Cited by 56
Mouritsen, S., Meldal, M., Christiansen‐Brams, I., Elsner, H. I., & Werdelin, O. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240509 · Cited by 50
Lai, Z., & Schreiber, J. R. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.03.064 · Cited by 48
Shimojo, N., Katsuki, T., Coligan, J. E., Nishimura, Y., Sasazuki, T., Tsunoo, H., Sakamaki, T., Kohno, Y., & Niimi, H. (2009) · International Archives of Allergy and Immunology · doi:10.1159/000236818 · Cited by 37
Colino, J., Chattopadhyay, G., Sen, G., Chen, Q., Lees, A., Canaday, D. H., Rubtsov, A. V., Torres, R. M., & Snapper, C. M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900238 · Cited by 31
Gad, M., Werdelin, O., Meldal, M., Komba, S., & Jensen, T. (2002) · Glycoconjugate Journal · doi:10.1023/a:1022537031617 · Cited by 7
Cited by
Li, S., Rouphael, N., Duraisingham, S., Romero-Steiner, S., Presnell, S., Davis, C., Schmidt, D. S., Johnson, S. E., Milton, A., Rajam, G., et al. (2014) · Nature Immunology · doi:10.1038/ni.2789 · Cited by 770
Lipopolyplex potentiates anti-tumor immunity of mRNA-based vaccination
Persano, S., Guevara, M. L., Li, Z., Mai, J., Ferrari, M., Pompa, P. P., & Shen, H. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.02.019 · Cited by 187
Dendritic Cells in Antifungal Immunity and Vaccine Design
Roy, R. M., & Klein, B. S. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.04.005 · Cited by 99
Pobre, K., Tashani, M., Ridda, I., Rashid, H., Wong, M., & Booy, R. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.01.047 · Cited by 76
Metadata
- Authors
- Avci, F. Y., Li, X., Tsuji, M., & Kasper, D. L.
- Venue
- Nature Medicine
- Published
- 2011-11-20
- Volume
- 17
- Issue
- 12
- Pages
- 1602-1609
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2112765785
- Cited by
- 366
- References
- 36
- FWCI
- 7.73
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
